Cutting Edge Research in Stem Cells and Cancer Immunotherapy to Be...

As modern oncology, largely directed towards developing therapies that achieve tumor reduction, has been thus far unsuccessful in achieving long term management of cancer, much more needs to be done in identifying and appropriately leveraging targets associated with tumor initiation, relapse or metastasis.

http://eon.businesswire.com/news/eon/20130131005120/en/Cutting-Edge-Research-Stem-Cells-Cancer-Immunotherapy